- Package
- 1 g
- Purity
- 98%
- Price
- Request review
- Availability
- Shipping review required
- Delivery
- Shipping review required
CAS Number: 870281-82-6
Submit an RFQ to review pricing, availability, lead time, pack size, purity, COA, and supplier SDS for this catalog entry.
Available options
Shipping review is required before pricing or stock can be confirmed publicly. Shipping, duties, and documentation fees are confirmed before order acceptance.
CAS Number
870281-82-6
PubChem CID
11625818
Molecular Formula
C22H18FN7O
Molecular Weight
415.4 g/mol
Exact Mass
415.155686
InChIKey
IFSDAJWBUCMOAH-HNNXBMFYSA-N
IUPAC Name
5-fluoro-3-phenyl-2-[(1S)-1-(7H-purin-6-ylamino)propyl]quinazolin-4-one
SMILES String
CC[C@@H](C1=NC2=C(C(=CC=C2)F)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5
Water Solubility
0.1 mol/L
Properties are provided as catalog reference data and may be confirmed through supplier documentation when required.
Structural features
Idelalisib (CAS 870281-82-6) is listed in the Pharmaceutical Intermediates portfolio, with molecular formula C22H18FN7O and molecular weight 415. 40 g/mol.
Sourcing context
Catalog reference for RFQ preparation, supplier confirmation, and research chemical sourcing review.
Research use context
Intended for research-stage medicinal chemistry and intermediate synthesis workflows; structure-derived tags include nitrogen-containing heterocycle.
Documentation needs
COA/SDS status, availability, lead time, pack size, and shipment documentation can be confirmed during quotation.
ChEMBL reports experimental activity evidence for: Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform (Homo sapiens) — 56 assays; PI3-kinase p110-delta/p85-alpha (Homo sapiens) — 11 assays; Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform (Homo sapiens) — 36 assays; Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform (Homo sapiens) — 28 assays; Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (Homo sapiens) — 25 assays. These records describe research assays and do not establish therapeutic efficacy or clinical use.
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform
Homo sapiens · SINGLE PROTEIN · 56 qualifying assays · 45 documents · best pChEMBL 9
Experimental evidence source: ChEMBL
PI3-kinase p110-delta/p85-alpha
Homo sapiens · PROTEIN COMPLEX · 11 qualifying assays · 9 documents · best pChEMBL 8.97
Experimental evidence source: ChEMBL
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform
Homo sapiens · SINGLE PROTEIN · 36 qualifying assays · 33 documents · best pChEMBL 7.6
Experimental evidence source: ChEMBL
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform
Homo sapiens · SINGLE PROTEIN · 28 qualifying assays · 26 documents · best pChEMBL 7.2
Experimental evidence source: ChEMBL
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
Homo sapiens · SINGLE PROTEIN · 25 qualifying assays · 23 documents · best pChEMBL 6.87
Experimental evidence source: ChEMBL
Safety and handling reference content is available through documentation requests.
For supplier-issued SDS, request documentation before handling, storage, shipment, or procurement decisions.
Preliminary Safety Reference
For supplier-issued SDS or COA, submit a documentation request.
Safety Reference / SDS RequestCatalog navigation
Other public CAS pages in this catalog. These links support navigation across additional intermediates and do not imply equivalence, availability, or shared use.
Idelalisib is identified by CAS 870281-82-6, with molecular formula C22H18FN7O, molecular weight 415.4, InChIKey IFSDAJWBUCMOAH-HNNXBMFYSA-N.
ChEMBL contains qualifying experimental assay evidence associated with Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform, PI3-kinase p110-delta/p85-alpha, Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform, Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform, Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform. These records do not establish therapeutic efficacy or clinical use.
Yes. Submit an RFQ and specify COA requirements. Lot-specific COA depends on supplier confirmation.
Yes. Supplier SDS can be requested through the RFQ workflow before handling, storage, shipment, or procurement decisions.
Availability, pack size, lead time, and pricing are confirmed through RFQ.
Submit the CAS number, quantity, purity requirement, and destination country for sourcing review.